Successful Treatment of AA Amyloidosis in Ankylosing Spondylitis Using Tocilizumab: Report of Two Cases and Review of the Literature

Historically, secondary amyloidosis has been a feared complication of chronic inflammatory conditions. The fibril protein AA derives from the acute phase reactant serum amyloid A (SAA). Long-term elevation of SAA levels remains a major risk factor for the development of AA amyloidosis in rheumatic d...

Descripción completa

Detalles Bibliográficos
Autores principales: Eriksson, Per, Mölne, Johan, Wirestam, Lina, Sjöwall, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107218/
https://www.ncbi.nlm.nih.gov/pubmed/33981717
http://dx.doi.org/10.3389/fmed.2021.661101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107218/
https://www.ncbi.nlm.nih.gov/pubmed/33981717
http://dx.doi.org/10.3389/fmed.2021.661101

Ejemplares similares